Naoki Inagaki Selected Research

Naoki Inagaki Research Topics

Disease

13	Inflammation (Inflammations) 12/2017 - 05/2002
12	Atopic Dermatitis (Atopic Eczema) 01/2019 - 04/2002
9	Hypersensitivity (Allergy) 06/2023 - 08/2004
9	Asthma (Bronchial Asthma) 01/2021 - 12/2006
9	Dermatitis 01/2019 - 09/2004
4	Food Hypersensitivity (Food Allergy) 04/2019 - 01/2017
4	Allergic Rhinitis 05/2016 - 09/2011
4	Pruritus (Itching) 01/2013 - 09/2006
4	Respiratory Hypersensitivity 10/2012 - 09/2003
3	Anaphylaxis (Anaphylactic Shock) 01/2017 - 09/2010
3	Airway Remodeling 01/2010 - 01/2008
3	Eosinophilia 01/2010 - 01/2008
2	Sneezing 05/2016 - 05/2016
2	Nasal Obstruction 05/2016 - 09/2011
2	Sick Building Syndrome 01/2012 - 06/2011
2	Arthritis (Polyarthritis) 11/2010 - 01/2010
2	Hypoxia (Hypoxemia) 01/2010 - 11/2008
2	Neoplasms (Cancer) 11/2009 - 02/2009
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Vitamin D Deficiency 04/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Egg Hypersensitivity (Egg Allergy) 12/2017
1	Diarrhea 12/2017
1	Mastocytosis 12/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 05/2016
1	Ischemia 08/2013
1	Reperfusion Injury 08/2013
1	Pain (Aches) 01/2013
1	Neurogenic Inflammation 01/2012
1	Rhinitis 01/2012
1	Contact Dermatitis (Eczema, Contact) 01/2012
1	Infarction (Infarctions) 01/2012
1	Stroke (Strokes) 01/2012
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2012
1	Allergic Contact Dermatitis 01/2012

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 06/2023 - 09/2003
10	Immunoglobulin E (IgE)IBA 10/2018 - 09/2006
7	OvalbuminIBA 06/2023 - 01/2010
6	AllergensIBA 07/2012 - 01/2008
5	DinitrofluorobenzeneIBA 01/2012 - 09/2006
4	CytokinesIBA 12/2017 - 08/2004
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2013 - 09/2006
4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2010 - 09/2006
3	Immunoglobulin G (IgG)IBA 10/2018 - 01/2010
3	Histamine (Histamine Dihydrochloride)FDA Link 05/2016 - 03/2008
3	Prostaglandin D2IBA 05/2016 - 01/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 03/2008
3	LipopolysaccharidesIBA 01/2010 - 04/2002
2	Complex MixturesIBA 05/2016 - 09/2004
2	Substance PIBA 01/2013 - 11/2010
2	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2013 - 09/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013 - 12/2006
2	PeriostinIBA 12/2012 - 07/2012
2	Interleukin-4 (Interleukin 4)IBA 10/2012 - 01/2010
2	Interleukin-13IBA 10/2012 - 11/2008
2	Formaldehyde (Formol)FDA Link 01/2012 - 06/2011
2	Nerve Growth Factors (Neurotrophins)IBA 01/2012 - 06/2011
2	AcetoneIBA 01/2010 - 09/2006
2	SolutionsIBA 01/2010 - 09/2006
2	LeukotrienesIBA 01/2010 - 04/2002
2	cobaltous chloride (cobalt(II)chloride)IBA 01/2010 - 11/2008
2	Group II Phospholipases A2IBA 05/2002 - 04/2002
1	montelukast (Singulair)FDA Link 01/2021
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021
1	LigandsIBA 01/2021
1	Vitamin D FDA LinkGeneric 04/2019
1	CeramidesIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2018
1	Translationally-Controlled 1 Tumor ProteinIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	eppikajutsutoIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	Syk KinaseIBA 08/2013
1	Retinaldehyde (Retinal)IBA 08/2013
1	Toll-Like Receptor 4IBA 08/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2013
1	Histamine Antagonists (Antihistamines)IBA 01/2013
1	NeuropeptidesIBA 01/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2013
1	Nigella sativa oilIBA 10/2012
1	Interleukin-5 (Interleukin 5)IBA 10/2012
1	IntegrinsIBA 07/2012
1	Prostaglandins DIBA 01/2012
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 01/2012
1	(N- methoxy- N- methyl)- 4- (5- benzoylbenzimidazole- 2- yl)- 3,5- dimethylpyrrole- 2- carboxamide hydrochlorideIBA 09/2011
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 09/2011
1	Xylenes (Xylene)IBA 06/2011
1	TolueneIBA 06/2011

Therapy/Procedure

4	Therapeutics 01/2013 - 12/2006
2	Kampo Medicine (Kampo) 01/2013 - 01/2005
2	Drug Therapy (Chemotherapy) 01/2013 - 11/2009
1	Skin Care 04/2019
1	Immunotherapy 12/2017
1	Oral Administration 01/2013
1	Traditional Medicine (Folk Remedies) 10/2012